Company Data
Aptose Biosciences Inc.
Ticker
APTO
Current Price
$1.71 -45.71%
Market Cap
$3.7M
Price Target
Refer to Report
Volume
640.7K
52wk Range
$2.3937 - $51.609
Overview
Aptose Biosciences Inc is a biotechnology company. It develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes and other hematologic malignancies and also therapies for Oncology. The firm has CG-806, APTO-253 drugs in preclinical development stage pipeline.